010 - "Don't Make Assumptions" with David Simoens

Let's Combinate · 8 Dec 2021 · 1h 13m

What this episode covers

David Simoens, COO of cGMP Consulting Group, explains how a risk-based approach can streamline commissioning, qualification, and validation (C&Q) in pharmaceutical manufacturing. He details the transition from traditional, repetitive testing to leveraging data from Factory Acceptance Tests (FAT) and Site Acceptance Tests (SAT) through rigorous User Requirement Specifications (URS) and risk assessments. Simoens highlights common pitfalls, such as poorly written 70-page URS documents and inadequate debugging at the vendor site, which lead to significant project delays and cost overruns. He emphasizes the importance of using tools like FMEA and ISPE guidelines to identify critical aspects early, ensuring that testing is performed once and leveraged through to Performance Qualification (PQ).

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 54m

    #329 The Right Way to Start a QMS: When, How, & What

    Rob MacCuspie, Manager of Regulatory and Quality Affairs at Proxima Clinical Research, explains how to build a Quality Management System (QMS) by balancing investor cost concerns with FDA regulatory requirements. He argues that a QMS is not just a document management system but a culture driven by management responsibility and people, using a 'highway vs. mountain road' analogy to describe risk-based rigor for different device classes. MacCuspie details the phased implementation of QMS components, the specific challenges of Software as a Medical Device (SaMD) regarding labeling and testing, and the operational efficiency gains of moving from paper to compliant electronic systems like Greenlight Guru.

  • Global Medical Device Podcast · 44m

    #384: Insights from an Ex-FDA Investigator: Compliance, Quality Systems, and MedTech Trends

    Vincent Cafiso, Director of Quality and Regulatory Services at Creo Consulting and former FDA investigator, discusses the critical need for MedTech companies to align R&D testing environments with production standards to avoid costly rework and data rejection. He highlights common pitfalls in design controls, such as missing real-time aging data and inadequate documentation in Design History Files, urging companies to integrate quality validation early in the development process. Cafiso also emphasizes the importance of management responsibility and breaking down organizational silos through skip-level meetings to maintain a collaborative, startup-like culture as companies scale from garage startups to enterprise levels.

  • Global Medical Device Podcast · 1h 08m

    #326 CSA vs. CSV: Modern Validation for Modern MedTech

    Sandra Rodriguez, an analyst at Axendia, discusses the FDA's shift from Computer System Validation (CSV) to Computer Software Assurance (CSA) in medical device manufacturing. She explains how CSA flips the traditional validation pyramid by prioritizing critical thinking and risk assessment over exhaustive documentation, significantly reducing the burden on companies. The conversation covers the industry's response to the September 2022 draft guidance, the role of GAMP 5, and the evolving relationship between life science companies and technology vendors like Greenlight Guru.

  • Global Medical Device Podcast · 32m

    #360: Is It Possible to "Buy" a QMS?

    Sara Adams, a quality engineering expert with extensive experience in FDA inspections, explains why Quality Management Systems (QMS) cannot be bought off-the-shelf, using a sourdough bread analogy to illustrate the need for customization. She details the layers of a QMS, from procedural documents to electronic storage, emphasizing that while tools like Greenlight Guru provide 'guardrails,' the specific procedures must be tailored to the company's risk profile and regulatory requirements. Adams highlights common pitfalls, such as using non-compliant signatures in SharePoint or paper-based systems, and stresses that the ultimate goal of any QMS decision is patient safety, not just passing an audit.

  • Global Medical Device Podcast · 31m

    Implementing an eQMS after Switching from Paper

    Kendyl Williams, a Medical Device Guru at Greenlight Guru, details her experience transitioning a medical device company from a paper-based Quality Management System (QMS) to the Greenlight Guru eQMS platform. She describes the logistical failures of the paper system, such as 'document signing parties' and lost binders, and explains how the team validated the new software by locking themselves in a coffee shop to test workflows. Williams highlights the importance of using the sandbox environment to learn the system without risking live data and emphasizes the need for intentional setup regarding document nomenclature and attributes to ensure traceability between risk and design controls.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.